A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

The engineering and functional characterization of the Fc domain are key to therapeutic antibodies’ efficacy, safety, and pharmacokinetics. The Fc domain is responsible for mediating interactions with ...

In a phase 2 trial, felzartamab showed acceptable safety and potential therapeutic benefits in kidney transplant recipients with antibody-mediated rejection. Felzartamab shows acceptable safety and ...